
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
eMS News is the monthly email newsletter distributed from the Rocky Mountain MS Center. Each issue contains articles and features on the latest developments at the Rocky Mountain MS Center and general MS news from around the world. Regular features include the latest information on current clinical trials and research studies, upcoming events, fundraising activities and more.
Beginning below, you’ll find archives of our eMS News updates all the way back to 2012.
Browse our latest updated, or search below to find the topic you’re looking for.
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
April 16-24, 2023 is National Volunteer Week! Please join us as we thank the wonderful volunteers who help us fulfill our mission: To improve the quality of life of individuals…
This session of Conversations on MS, featuring Dr. Anna Shah of the Rocky Mountain MS Center, was recorded on Wednesday, March 29, 2023. Conversations on MS is an audience-directed discussion…
Want to get out of your comfort zone and into an adrenaline rush? Our friends at First Descents (FD) provide free, life-changing outdoor adventures for young adults (ages 18-45) living…
The U.S. Food and Drug Administration has approved Briumvi (ublituximab) as a disease-modifying therapy for adults with relapsing forms of MS. And as of late January, this DMT is now commercially…
There are now several generic versions of the common MS drug Gilenya approved for use in the United States. Patients currently taking Gilenya should be aware that this could impact…
Welcome to a very special edition of Conversations on MS! This session features three MS-specialist neurologists answering frequently asked questions. Dr. John Corboy moderates the event. Corboy is the Medical…





